Verdane, the European specialist growth buyout investment firm, announced that it has acquired a portfolio of ownership stakes in four technology businesses from Trifork Labs, the venture-financed R&D division of Trifork Group. The transaction will see Verdane partner with Axoniq, the pioneer in event-sourcing architecture; Dawn Health, a patient-centric digital health business; and Frameo, the world’s largest software provider for WiFi photo frames, enabled by a joint ownership structure alongside Trifork Group. Verdane has also directly acquired an ownership stake in XCI, a cybersecurity business delivering communication intelligence solutions.
Through the transaction, Verdane will partner with the companies’ management teams, helping them continue their growth with the support of Verdane’s in-house operational advisors across functions including go-to-market, data, finance, and talent. The acquisition draws on Verdane’s more than 20 years of experience executing over 50 portfolio deals, with the flexible mandates of its Freya funds enabling the firm to source such complex transactions.
Trifork Group, listed on Nasdaq Copenhagen, is a global technology company specializing in designing, building, and operating advanced software for enterprise and public sector customers, with 1,102 full-time employees across 16 countries. Since its IPO in 2021, the Labs portfolio has realized net cash proceeds of €44 million after deducting invested capital, management costs, and impairments, with profit over the last 10 years reaching €114 million. Verdane has raised €10 billion in capital and made more than 200 investments in fast-growing businesses since 2003, with a team of over 180 investment professionals based across Berlin, Copenhagen, London, Helsinki, Munich, Oslo, and Stockholm.
KEY QUOTES:
“Trifork’s strong track record of building and investing in tech companies at the early stage of development is an excellent fit with Verdane’s focus on companies that have proven their global potential at scale.”
“We will now introduce our expertise and deep investment capacity to Axoniq, Dawn Health, Frameo, and XCI and help them grow to the next level. We hope to be able to increase our stakes in these companies over time, but we also see other high-potential companies in Trifork Labs that we could partner with in the future.”
Emanuel Johnsson, Partner, Verdane
“Today is a very good day for Trifork Group. Solid performance across the Labs portfolio has resulted in consistently increasing unrealized gains over the years.”
“We have found a skilled, resourceful, and recognized partner in Verdane — not just for Trifork, but also for the four Labs companies included in this transaction. I look forward to seeing the partnership with Verdane come to fruition in the coming years, and to work towards the next exits we already see on the horizon.”
Jørn Larsen, Founder and CEO, Trifork Group
